Skin Repair
GHK-Cu promotes collagen synthesis while BPC-157 and TB-500 support epithelial repair and reduce scarring.
Pickart & Margolina 2018
A skin-and-repair blend for collagen and healthier skin
Free Shipping on orders over $200
Scan the QR code on any vial to verify its batch, COA, and origin in seconds. Secure traceability from our lab to your bench.
Glow is a skin-and-repair blend of three complementary peptides — BPC-157, TB-500, and GHK-Cu — researched together for collagen production, tissue regeneration, and healthier, more radiant skin.
Three-peptide research blend: BPC-157 + TB-500 + GHK-Cu
The pathways Glow acts on — and what each one does. The animation traces its signal outward from the compound to every target it engages.
Promotes blood vessel formation, enhances tissue granulation, and modulates nitric oxide signaling for vascular support to damaged tissue.
Increases cell migration, supports cytoskeletal remodeling, and reduces fibrotic scarring through thymosin beta-4 pathway activation.
Stimulates type I & III collagen synthesis, modulates 4,000+ genes, and delivers copper to repair sites for extracellular matrix rebuilding.
The main areas Glow is being studied for — and the study-reported figures behind them.
GHK-Cu promotes collagen synthesis while BPC-157 and TB-500 support epithelial repair and reduce scarring.
Pickart & Margolina 2018TB-500 facilitates actin remodeling; BPC-157 promotes tendon fibroblast viability; GHK-Cu supports vascularization.
Chi et al. 2017All three peptides demonstrate anti-inflammatory properties through different mechanisms in animal models.
Hsieh et al. 2016Coordinated extracellular matrix deposition for functional, less fibrotic tissue regeneration.
Brcic et al. 2011An interactive 3D model rendered from the compound record — rotate and explore its structure.
Molecular model
Every batch of Glow is sent to an accredited independent laboratory before it ships. Here is what we screen for.
| Components | BPC-157 + TB-500 + GHK-Cu |
| Strength | 70mg |
| Form | Lyophilized powder |
| Purity | ≥99% (HPLC verified per component) |
| Testing | Third-party HPLC, Mass Spec, Endotoxin |
| Storage (Lyophilized) | -20°C for long-term stability |
| Storage (Reconstituted) | 2–8°C, use within 7 days |
| Light Sensitivity | Protect from direct light at all times |
| Solubility | Bacteriostatic water for reconstitution |
| COA | Included with every order |
| Appearance | White to off-white powder |
| Stability | 24 months from manufacture date when stored properly |
GLOW is a research peptide blend containing three complementary peptides: BPC-157 (Body Protection Compound), TB-500 (Thymosin Beta-4), and GHK-Cu (copper peptide). Each targets a different phase of tissue regeneration — vascular support, cell migration, and collagen synthesis respectively.
In preclinical research, BPC-157 promotes blood vessel formation (angiogenesis) to deliver nutrients to damaged tissue. TB-500 enhances cell migration to injury sites through actin regulation. GHK-Cu stimulates collagen production and modulates over 4,000 genes involved in tissue remodeling. Together they address three distinct but complementary phases of regeneration.
No. GLOW is not approved by the FDA for any medical use. It is sold exclusively for in vitro laboratory research purposes. The individual components have varying levels of preclinical evidence but no completed human clinical trials for the combined blend.
Store lyophilized (powder) form at -20°C for maximum stability. After reconstitution with bacteriostatic water, refrigerate at 2–8°C and use within 7 days. Protect from direct light at all times. Do not freeze reconstituted solution.
Each component undergoes independent third-party testing including HPLC (High Performance Liquid Chromatography) for purity verification, mass spectrometry for molecular weight confirmation, and endotoxin testing. Certificates of Analysis are included with every order.
The evidence is based on individual component research: BPC-157 has 200+ preclinical publications, TB-500 has 170+ publications, and GHK-Cu has 130+ publications. The combined blend has not been studied as a single formulation in clinical trials. Synergy is inferred from mechanistic complementarity.
Independent published research indexed from PubMed and peer-reviewed journals — not Eon Peptides claims.
Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.